← Alle mensen

AL

Alessandra Larocca

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2025

Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patiënten met newly diagnosed myeloma ine...

The Lancet. Haematology · 2025-08

Elotuzumab plus Rd bij niet-transplanteerbaar myeloom: ELOQUENT-2 langetermijn

The Lancet. Haematology · 2022-06

Aangepaste Rd versus continue Rd bij ouderen met myeloom: fase III

Blood · 3 juni 2021

Pembrolizumab plus pomalidomide-dexamethason bij recidief myeloom: KEYNOTE-183

The Lancet. Haematology · 2019-09